Last edition
News about "Apogee Therapeutics"
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie completes its acquisition of Apogee Therapeutics, strengthening its immunology pipeline with assets targeting dermatologic, respiratory and inflammatory diseases.
Apogee Therapeutics | 05/09/2026 | By News Bureau
AbbVie to Acquire Apogee Therapeutics
AbbVie plans to acquire Apogee Therapeutics, expanding its immunology portfolio with a diverse pipeline of innovative therapies for dermatologic, respiratory, inflammatory, and immune-mediated diseases.
Apogee Therapeutics | 23/06/2026 | By News Bureau | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy